Active Pharmaceutical Ingredients Market 2017-2026 - Global Report 2018 - ResearchAndMarkets.com
The "Active Pharmaceutical Ingredients - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
According to this report, the Global Active Pharmaceutical Ingredients market accounted for $151.89 billion in 2017 and is expected to reach $308.48 billion by 2026, growing at a CAGR of 8.2% from 2017 to 2026.
Increase in incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals are some factors fueling the market growth. However, factors such as stringent regulatory requirements and unfavorable drug price control policies across various countries are restricting the market growth.
Amongst customer base, the generic segment accounted for significant market share during the forecast period. Generic drugs benefit from the patent expiration of innovative drug as it makes them readily available in the market. The demand to produce quality medicines at lower and affordable costs creates a scenario, where the needs for generic drugs increase.
By geography, Asia Pacific dominated the market due to the rising healthcare spending which has led to quality healthcare becoming accessible along with a higher demand for pharmaceutical products across APAC. The pharmaceuticals consumed here are mostly produced in onshore manufacturing units. Furthermore, contract manufacturing organizations are key outsourcing allies for pharmaceutical companies that supply their wares across the region.
Key Topics Covered
1 Executive Summary
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Active Pharmaceutical Ingredients Market, By Drug Type
6 Global Active Pharmaceutical Ingredients Market, By API Formulation
7 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer
8 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis
9 Global Active Pharmaceutical Ingredients Market, By API Type
10 Global Active Pharmaceutical Ingredients Market, By Molecule
11 Global Active Pharmaceutical Ingredients Market, By Application
12 Global Active Pharmaceutical Ingredients Market, By Geography
13 Key Developments
14 Company Profiling
- Teva Active Pharmaceutical Industries Limited
- Ranbaxy Laboratories
- Pfizer, Inc
- Mylan N.V.
- Dr. Reddy's Lab
- Boehringer Ingelheim GmbH
- Aurobindo Pharma
- Albemarle Corporation
- Ceva Animal Health, Inc.
- Sun Pharmaceutical Industries Ltd.
- Merck Animal Health (U.S.)
- Elanco Animal Health (U.S.)
- Zoetis (U.S.)
- Merial Inc. (Sanofi) (France)
- Bioniche Animal Health (Canada)
- Bayer Healthcare (Germany)
- ELI Lilly and Company
- GlaxoSmithKline PLC
- Abbvie Inc.
- Bristol-Myers Squibb
For more information about this report visit https://www.researchandmarkets.com/research/w43bzb/active?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181101005763/en/